Premium
The effects of α‐secretase ADAM10 on the proteolysis of neuregulin‐1
Author(s) -
Freese Christian,
Garratt Alistair N.,
Fahrenholz Falk,
Endres Kristina
Publication year - 2009
Publication title -
the febs journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.981
H-Index - 204
eISSN - 1742-4658
pISSN - 1742-464X
DOI - 10.1111/j.1742-4658.2009.06889.x
Subject(s) - neuregulin 1 , adam10 , neuregulin , amyloid precursor protein secretase , chemistry , gene knockdown , microbiology and biotechnology , proteolysis , metalloproteinase , amyloid precursor protein , biology , alzheimer's disease , receptor , medicine , biochemistry , matrix metalloproteinase , enzyme , disease , apoptosis , disintegrin
Although ADAM10 is a major α‐secretase involved in non‐amyloidogenic processing of the amyloid precursor protein, several additional substrates have been identified, most of them in vitro . Thus, therapeutical approaches for the prevention of Alzheimer’s disease by upregulation of this metalloproteinase may have severe side effects. In the present study, we examined whether the ErbB receptor ligand neuregulin‐1, which is essential for myelination and other important neuronal functions, is cleaved by ADAM10. Studies with β‐ and γ‐secretase inhibitors, as well as with the metalloproteinase inhibitor GM6001, revealed an inhibition of neuregulin‐1 processing in human astroglioma cell line U373; however, specific RNA interference‐induced knockdown of ADAM10 remained without effect. In vivo investigations of mice overexpressing either ADAM10 or dominant negative ADAM10 showed unaltered cleavage of neuregulin‐1 compared to wild‐type animals. As a consequence, the myelin sheath thickness of peripheral nerves was unaffected in mice with altered ADAM10 activity. Thus, although the β‐secretase BACE‐1 acts as a neuregulin‐1 sheddase, ADAM10 does not lead to altered neuregulin‐1 processing either in cell culture or in vivo . Adverse reactions of an ADAM10‐based therapy of Alzheimer’s disease due to neuregulin‐1 cleavage are therefore unlikely.